BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2023 financial results before market opening on Thursday, May 4, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 1, 2023. First Quarter 2023 Highlights Delivered very strong financial results during the first quarter. First quarter revenue was $10.71 billion, 9% lower versus the same quarter last year.... Read more
WASHINGTON, April 25, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the first quarter 2023. Net earnings refer to net earnings attributable to common shareholders. For the quarter ended March 31, 2023 net earnings were $1.4 billion, or $1.94 per diluted common share and non-GAAP adjusted diluted net earnings per... Read more
(Peabody, MA and Pittsburgh, PA) — JEOL USA and Cumberland Additive, Inc. (CAI) are pleased to announce that Cumberland’s Neighborhood 91 facility in Pittsburgh will be the first installation in North America of JEOL’s new Electron Beam Melting (EBM) Powder Bed Fusion (PBF) system. This new metal 3D Printed E-Beam system will expand capabilities, primarily... Read more
ANDOVER, Mass., April 17, 2023 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release first quarter 2023 financial results after market close on Wednesday, May 3, 2023. Read more
Advancements in NMR enable deeper insights into life science, drug discovery, and cleantech ASILOMAR, Calif.–(BUSINESS WIRE)– At the Experimental Nuclear Magnetic Resonance Conference (ENC 2023), Bruker announces innovations for NMR spectroscopy in life science, pharma, and cleantech research to enable discoveries in functional structural biology, drug discovery, and battery research. Ascend Evo 400 NMR magnet... Read more
Introduction of a FFPE workflow extends the tissue proteomics applications of PreOmics’ unique BeatBox™ technology Launch of novel FFPE workflow enables high-throughput, robust and fast processing of tissue samples Bruker and PreOmics to co-commercialize BeatBox workflows ORLANDO, Fla.–(BUSINESS WIRE)– At the AACR Annual Meeting 2023, PreOmics GmbH announced the launch of a BeatBox-based FFPE workflow,... Read more
MBT Mycobacteria IVD Kit optimizes sample preparation and comprehensive library of MBT HT Mycobacteria IVD Module MBT HT Filamentous Fungi IVD Module incorporates extensive fungal library with easy and effective sample preparation (MyT) New MBT Compass HT IVD software significantly increases speed for microbial identification, with unique automated self-tuning New LiquidArray® Gastrointestinal PCR Panel detects... Read more
Enable Cloud Platform to be Available with Canopy CellScape System for High-Plex Spatial Biology ST. LOUIS & MENLO PARK, Calif.–(BUSINESS WIRE)– Canopy Biosciences, a Bruker Company, and Enable Medicine, today announced a partnership to provide Enable Medicine’s advanced analysis pipelines for spatial omics data with the Canopy CellScape™ system for quantitative high-plex spatial biology. The... Read more
Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock WASHINGTON, April 10, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its 5.00% Series B Mandatory Convertible Preferred Stock (the “Preferred Stock”), will automatically convert into shares of the Company’s common stock on April 17, 2023 (the “Conversion Date”). The conversion rate... Read more